Skip to ContentSkip to Navigation
Practical matters How to find us dr. B.T. Santema


Atrial function in paroxysmal AF patients with and without heart failure with preserved ejection fraction: Data from the AF-RISK study

Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure

Differences in biomarkers and molecular pathways according to age for patients with HFrEF

Improvement in left ventricular ejection fraction after pharmacological up-titration in new-onset heart failure with reduced ejection fraction

Pathophysiological pathways in patients with heart failure and atrial fibrillation

Quality of life in men and women with heart failure: association with outcome, and comparison between the Kansas City Cardiomyopathy Questionnaire and the EuroQol 5 dimensions questionnaire

Sex differences and atrial fibrillation in heart failure with reduced versus preserved ejection fraction

Sex-Specific Differences in Heart Failure: Pathophysiology, Risk Factors, Management, and Outcomes

Circulating plasma concentrations of angiotensin-converting enzyme 2 in men and women with heart failure and effects of renin-angiotensin-aldosterone inhibitors

Ethnic differences in atrial fibrillation among patients with heart failure in Asia

Read more


Dit is waarom mannen en vrouwen anders reageren op dezelfde medicijnen